MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Nirav Biosolutions

U33100PN2012PTC142482ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed

Nirav Biosolutions is a Private Indian company incorporated in 2011 and based in PN, India. Nirav Biosolutions operates in Medical & Precision (NIC 33100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2011
15 years old
State
PN
Sector
Medical & Precision
NIC 33100
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
Nirav BiosolutionsTRACXN · PUBLIC DATA
Brand Nirav Biosolutions · Legal entity Nirav Biosolutions

Nirav Biosolutions - Provider of cell culture and microbiology reagents for the life science industry.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
12
Stage
Unfunded
HQ
Pune
Founded
2011
Source: Tracxn (public profile) · joined to MCA on CIN U33100PN2012PTC142482

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
33100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Medical & Precision
ROC
—
Website
https://niravbiosolutions.com
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
VS
Vikram Singh Rathore
Whole-time Director
2.8y · Ahmedabad · DIN 6140162
DR
Deepa Reddy
Director
8.3y · Chennai · DIN 9159325
AD
Anita Desai
Director
6.7y · Hyderabad · DIN 9858157
Get the full board of directors

Directors, DINs & appointment history for Nirav Biosolutions.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 2024+9dfiled
MGT-7FY2024-2526 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2420 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 2022+30dfiled
MGT-7FY2022-2323 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Nirav Biosolutions.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
408921757Axis Bank Ltd(Bank)₹10.23 Cr12 Mar 2022Satisfied
807684562State Bank of India(Bank)₹1.94 Cr04 Jul 2022Open
188412310State Bank of India(Bank)₹17.60 Cr12 Mar 2020Open
997752805Kotak Mahindra Bank Ltd(Bank)₹8.42 Cr12 Mar 2019Open
See registered charges & lenders

Charge IDs, lenders & amounts for Nirav Biosolutions.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹65.43 Cr₹8.26 Cr₹48.51 Cr₹79.93 Cr184
FY2023-24₹55.38 Cr₹7.80 Cr₹32.48 Cr₹81.86 Cr260
FY2022-23₹40.71 Cr₹6.04 Cr₹30.02 Cr₹68.15 Cr23
FY2021-22₹42.76 Cr₹5.75 Cr₹20.33 Cr₹41.51 Cr111
Gain deeper financial insights of this entity

Audited financials & ratios for Nirav Biosolutions.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹65.43 Cr₹55.38 Cr₹40.71 Cr₹42.76 Cr
Other income₹1.82 Cr₹49.85 L₹1.58 Cr₹67.99 L
Total income₹67.26 Cr₹55.87 Cr₹42.30 Cr₹43.44 Cr
Total expenses₹56.68 Cr₹45.89 Cr₹34.57 Cr₹36.08 Cr
Profit before tax₹10.74 Cr₹10.14 Cr₹7.85 Cr₹7.47 Cr
Profit / (Loss) after tax₹8.26 Cr₹7.80 Cr₹6.04 Cr₹5.75 Cr
Balance sheet
Equity / Net worth₹48.51 Cr₹32.48 Cr₹30.02 Cr₹20.33 Cr
Borrowings₹6.44 Cr₹15.84 Cr₹20.04 Cr₹4.55 Cr
Current liabilities₹17.44 Cr₹20.45 Cr₹18.98 Cr₹11.95 Cr
Total liabilities₹31.42 Cr₹49.38 Cr₹38.13 Cr₹21.18 Cr
Current assets₹41.60 Cr₹43.87 Cr₹29.05 Cr₹21.65 Cr
Cash & equivalents₹8.54 Cr₹9.08 Cr₹8.72 Cr₹5.83 Cr
Total assets₹79.93 Cr₹81.86 Cr₹68.15 Cr₹41.51 Cr
Employees18426023111
Gain deeper financial insights of this entity

Audited financials & ratios for Nirav Biosolutions.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹65.43 Cr+25.1%+14.2%+14.0%
Profit after Tax₹8.26 Cr+34.2%+17.9%+7.1%
Net Worth₹48.51 Cr+26.7%+27.7%-1.7%
Employees184+7.4%+16.1%+4.5%
Gain deeper financial insights of this entity

Audited financials & ratios for Nirav Biosolutions.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹65.43 Cr₹8.26 Cr+12.62%-7.00%+17.03%+10.33%0.13₹35.56 L
FY2023-24₹55.38 Cr₹7.80 Cr+14.09%+8.62%+24.02%+9.53%0.49₹21.30 L
FY2022-23₹40.71 Cr₹6.04 Cr+14.83%+4.47%+20.11%+8.86%0.67₹1.77 Cr
FY2021-22₹42.76 Cr₹5.75 Cr+13.44%+16.00%+28.26%+13.84%0.22₹38.52 L
Gain deeper financial insights of this entity

Audited financials & ratios for Nirav Biosolutions.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters31,37,98,45270.22%
Institutional Investors228,73,20114.62%
Public & Others2329,77,90715.16%
See the full shareholding pattern

Promoter, institutional & public holding for Nirav Biosolutions.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

7 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P0

Top 10 in Medical & Precision

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Jlnphenix Energy
Uttar Pradesh · Inc 2008
Paid-up
Revenue
C · 63
05
Plenum Tech
Maharashtra · Inc 2000
Paid-up
Revenue
C · 63
06
Medived
Karnataka · Inc 2006
Paid-up
Revenue
C · 63
07
Insightra Medical Private Limited
Maharashtra · Inc 2005
Paid-up
Revenue
C · 63
08
Aalay Surgicals
Gujarat · Inc 2010
Paid-up
Revenue
C · 63
09
Goenka Jewellers
West Bengal · Inc 1990
Paid-up
Revenue
C · 63
10
Paid-up
Revenue
C · 63

Events & timeline

3Filings, charges, board changes
07 Mar 2012
Shyam appointed as Director
07 Mar 2012
Pravin appointed as Director
07 Mar 2012
Vaishali appointed as Director

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Nirav Biosolutions

When was Nirav Biosolutions incorporated?
Nirav Biosolutions was incorporated in 2011. Its CIN is U33100PN2012PTC142482 and it is registered with the relevant Registrar of Companies.
Where is Nirav Biosolutions located?
Nirav Biosolutions is headquartered in PN.
What sector does Nirav Biosolutions operate in?
Nirav Biosolutions operates in the Medical & Precision sector (NIC code 33100), classified as Indian Non-Govt Company.
Who are the directors of Nirav Biosolutions?
Director details for Nirav Biosolutions have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Nirav Biosolutions?
Nirav Biosolutions has authorized capital of — and paid-up capital of —.
Does Nirav Biosolutions have any open charges?
Nirav Biosolutions has no open MCA-registered charges on record.
What is Nirav Biosolutions's Compliance Health Score?
RegisterKaro's Compliance Health Score for Nirav Biosolutions is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.